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Objectives   The aim of this study was to investigate the association between the length of sickness absence and 
sustained return to work (SRTW) and the predictors of SRTW in depression, anxiety disorders, intervertebral disc 
disorders, and back pain in a population-based cohort of employees in the Finnish public sector.
Methods   We linked data from employers’ registers and four national population registers. Cox proportional 
hazards regression analysis with a cluster option was applied. SRTW was defined as the end of the sickness 
benefit period not followed by a recurrent sickness benefit period in 30 days.
Results  For depression, the median time to SRTW was 46 and 38 days among men and women, respectively. 
For anxiety disorders, the figures were 24 and 22 days, for intervertebral disc disorders, 42 and 41 days, and, 
for back pain, 21 and 22 days among men and women respectively. Higher age and the persistence of the health 
problem predicted longer time to SRTW throughout the diagnostic categories. Comorbid conditions predicted 
longer time to SRTW in depression and back pain among women.
Conclusions   This large cohort study adds scientific evidence on the length of sickness absence and SRTW 
in four important diagnostic categories among public sector employees in Finland. Further research taking into 
account, eg, features of the work environment is suggested. Recommendations on the length of sickness absence 
at this point should be based on expert opinion and supplemented with research findings.
Key terms   evidence-based practice; Finland; population register; practice guideline; RTW; sick leave; suc-
cessful return to work.
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Prescribing sick leave is one of the most frequently used 
procedures in healthcare. In Finland, a Nordic country 
with a 2.6 million working population, the Social Insur-
ance Institution of Finland compensated 14.4 million 
medically certified sickness benefit days in 2015 cor-
responding to a cost of 826 million euros (1). Of the 
compensated sickness benefit days, 32% were related to 
musculoskeletal diseases and 26% to mental disorders. 
In these categories, depression and back pain were 
among the most frequent causes of compensated work 
absence. A cautious estimate of the average overall cost 
of absenteeism to a nation is 2.2% of GDP (2).
Sickness absence is not only costly for the organiza-
tions and the society, but also for the individual. It is 
known from previous studies that long-term sickness 
absence is a prognostic marker of future absence from 
work, early retirement due to ill health, and mortality 
(3–9). Long-term sickness absence is also associated with 
future unemployment, financial difficulties, psychological 
and social problems, and social exclusion (10–12). On 
the other hand, there is evidence that staying active, eg, 
in case of low-back pain, promotes recovery (13). Since 
a timely return to work both reduces expenses from sick-
ness benefits and prevents long-term work disability, it 
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would be important to pay attention to the length of sick-
ness absences and encourage return to work.
In several countries, for example Sweden, certify-
ing physicians are provided with recommendations for 
the assessment of the need and the duration of sickness 
absence (14, 15). The guidelines mostly stem from expert 
consensus, since prescribing sick leave has not been 
evidence-based as many other medical procedures or 
recommendations are, regardless of the seriousness of the 
related public health problem (16). A limitation of stud-
ies on the length of sickness absence preceding sustained 
return to work (SRTW) is that they have typically been 
carried out among participants who already at the begin-
ning of the study had been absent from work for a longer 
period of time (17–21). Also, the majority of the RTW 
studies originate from one country, namely the Nether-
lands, which limits the generalizability of the findings.
The aim of this study was to add scientific evi-
dence on the associations between the length of sick-
ness absence and SRTW in Finland. We investigated 
the length of sickness absence from the initial day of 
absence until SRTW and the predictive factors of SRTW. 
We studied sickness absences lasting ≥10 weekdays in 
four diagnostic categories in a large cohort of Finnish 
public sector employees. We modelled the cumulative 
probability of SRTW in the different diagnostic catego-
ries adjusting for sociodemographic factors, the persis-
tence of the health problem and comorbid conditions.
Methods
Population and data sources
The public sector is a significant employer and a branch 
of industry in Finland engaging currently more than half 
a million employees. The study cohort consisted of par-
ticipants of the Finnish Public Sector Study. This study 
is the largest follow-up study of public sector employees 
in Finland representing 20% of the country’s public sec-
tor employees (22). The eligible population worked in 
ten municipalities and six hospital districts. In the cur-
rent analysis, we focused on those employees who were 
working on 1 January 2005 (N=123 506).
Employers’ registers provided information on 
sociodemographic factors of the participants. Data on 
medically certified compensated sickness benefit peri-
ods were drawn from the national Sickness Insurance 
Register. The Finnish national sickness benefit scheme 
(23) compensates for work incapacity due to illness 
after the employer period of ten weekdays. All non-
retired citizens aged 16–67 are eligible for the benefit. 
Compensation for lost income is based on annual earn-
ings of the individual and the maximum length of the 
compensation period per disease is 300 weekdays in 
two years. The Sickness Insurance Register provides 
the starting and the ending dates for medically certified 
and compensated sickness absence periods with Inter-
national Classification of Diseases (ICD-10) codes. Of 
all 169 330 compensated sickness absence periods in 
2005–2011, 419 (0.2%) were lacking ICD–10 codes. 
These cases were categorized as “other causes”. Data on 
reimbursed medication purchases with codes from the 
Anatomical Therapeutic Chemical (ATC) classification 
system were obtained from the Drug Reimbursement 
Register. The Special Refund Entitlement Register 
includes information on individuals who are entitled to 
a specific refund for medication purchases due to certain 
severe and long-lasting conditions. The Hospital Dis-
charge Register provided data on hospitalization periods 
(dates and ICD-10 codes). Of all 169 330 compensated 
sickness absence periods in 2005–2011, 1368 (0.8%) 
were preceded by a hospitalization period for ICD-10 
F-diagnoses and 11 103 (6.6%) by a hospitalization 
period for ICD-10 M-diagnoses. Data from these distinct 
registers were combined on the basis of personal social 
security numbers of the participants.
Sustained return to work (SRTW)
The observational unit in the analysis was a medically 
certified and compensated sickness absence period in 
depression (F32, F33, and F34), anxiety disorders (F40, 
F41, F42 and F43), intervertebral disc disorders (M51) 
or back pain (M54). Each sickness absence period was 
computed as starting from the beginning of the employer 
period (the initial day of work absence) until the end of 
the compensation period (ie, adding ten weekdays to 
each compensated sickness absence period). Following 
regulations of the Finnish National Health Insurance, two 
consecutive sickness absence periods with same diagnosis 
were regarded as one if the working period in between 
the two work absence periods lasted <30 calendar days. 
Sickness absence periods that were <10 days (ie, not 
compensated) were not available in the data. SRTW was 
defined as the end of the sickness benefit period that was 
not followed by a recurrent sickness absence period for 
same diagnosis in 30 days. Out of all sickness absence 
periods in the data after year 2007 (when partial sickness 
benefit was first introduced in Finland), 1232 (0.6%) 
were partial sick leaves. Partial and full sickness absence 
periods were not differentiated in the analyses.
Baseline characteristics
Employers’ registers provided information on partici-
pants’ sex, age and occupation (in 2004 or during the 
latest employment in the public sector). Occupation 
was categorized into four main categories according to 
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the International Standard Classification of Occupations 
(ISCO): (i) managers and professionals (ISCO 1-2), (ii) 
associate professionals and clerks (ISCO 3-4), (iii) ser-
vice and care workers (ISCO 5), and (iv) manual work-
ers (ISCO 6-9). In order to adjust for possible regional 
differences in sick leave prescribing practices, sickness 
absence behavior, and the social context, information 
on the geographical location (region) of the participants 
work organization at the start of the follow-up was 
included in the analyses, categorized into Southern, 
Central and Northern Finland.
Persistence of the health problem was estimated with 
previous sickness absences and previous notifications of 
mental disorders or musculoskeletal diseases. Previous 
sickness absences were calculated during the previous 
year due to mental disorders (ICD-10 F), musculoskel-
etal diseases (ICD-10 M) or other causes (no/yes). Previ-
ous notifications of mental disorders or musculoskeletal 
diseases were evaluated as purchases of antidepressants 
(ATC classification system code N06A) or hospital-
ization due to mental disorders (no/yes); reimbursed 
purchases of medication for musculoskeletal pain (ATC 
classification system codes M01 (anti-inflammatory and 
anti-rheumatic products), M03 (muscle relaxants) and/or 
N02 (analgesics)) or hospitalization for musculoskeletal 
diseases. Purchases of medication and hospitalization 
periods were recorded during the sickness absence 
period under study, in the preceding 30 days and during 
the following 7 days after the sickness absence period. 
Comorbid conditions were assessed as entitlement to 
special reimbursements (due to diabetes, rheumatoid 
arthritis, asthma/COPD or coronary heart disease) at 
the beginning of the sickness absence period (no/yes).
Statistical analysis
Survival analysis (Cox proportional hazards model with 
a cluster option) was applied to estimate hazard ratios 
(HR) with 95% confidence intervals (95% CI) for SRTW 
and time (calendar days) from the beginning of sickness 
absence episode (2005–2011) to SRTW. This method 
allowed us to take into account the intra-individual cor-
relation of sickness absence periods by using sandwich 
variance estimates in calculating standard errors. Obser-
vations were right censored in case of disability pension, 
old age pension, death and end of the follow up (31 
December 2011). Kaplan-Meier curves were obtained to 
present a visual comparison of SRTW between diagnos-
tic groups. Analyses were carried out separately for men 
and women. The SAS 9.4 statistical package was used 
for all analyses (SAS Institute Inc, Cary, NC, USA).
Results
The baseline characteristics of the study participants 
are presented in table 1. Of the participants, 76% were 
women. The distributions of age and occupational posi-
tion followed the characteristics of the public sector in 
Finland among both men and women. Between 2005 
and 2011, 5% of the men and 9% of the women were 
prescribed sick leave due to depression. For anxiety dis-
orders, the respective figures were 4% and 9%, 2% among 
both sexes for intervertebral disc disorders, and 6% and 
8%, among men and women respectively for back pain.
Of sickness absence periods compensated during the 
follow-up due to depression, 80% were associated with 
SRTW. For anxiety disorders, the respective figure was 
93%, for intervertebral disc disorders 84% and for back 
pain 92%. Figure 1 shows a comparison of the unadjusted 
cumulative probability of SRTW in different diagnostic 
categories. Among men with depression, 50% of sick-
ness absence periods had resulted in a SRTW in 46 days 
[interquartile range (IQR) 24–117]. Among women, the 
corresponding figures were 38 days (IQR 21–88). Among 
men with anxiety disorders, 50% of sickness absence 
periods had resulted in a SRTW in 24 days (IQR 17–45). 
And among women, correspondingly in 22 days (IQR 
16–39). For intervertebral disc disorders, the correspond-
ing figures were 42 days (IQR 21–91) among men and 
41 days (IQR 20–84) among women. For back pain, 21 
days (IQR 15–39) and 22 days (IQR 15–42), respectively.
Table 2 displays associations between baseline 
Table 1. Participants’ (N=123 506) characteristics by sex.
Men  
(N=29 997) a
Women  
(N=93 509) b
N % N %
Age (years)
18–35 8069 26.9 26 133 28.0
36–45 9284 31.0 28 296 30.2
46–55 8352 27.8 26 907 28.8
≥56 4292 14.3 12 173 13.0
Occupational group c
Managers and professionals 11 236 37.5 26 989 28.9
Associate professionals and clerks 6135 20.5 31 050 33.2
Service and care workers 3184 10.7 22 911 24.5
Manual workers 9375 31.3 12 527 13.4
Region
Southern Finland 15 672 52.3 51 261 54.8
Central Finland 8893 29.7 27 784 29.7
Northern Finland 5432 18.0 14 464 15.5
Diagnostic category (ICD–10) (2005–11)
Depression (F32, F33, F34) 1628 5.4 8392 9.0
Anxiety disorders (F40, F41, F42, F43) 1231 4.1 8067 8.6
Intervertebral disc disorders (M51) 642 2.1 1978 2.1
Back Pain (M54) 1773 5.9 7700 8.2
a Mean age 43.1 (SD 10.2) years.
b Mean age 42.7 (SD 10.3) years.
c Missing N=99.
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characteristics and SRTW in depression (full models). 
Median time until SRTW ranged from 33–57 days 
among men and 31–40 days among women, depending 
on the age-group, longer time to SRTW being associ-
ated with higher age (>46 years). The persistence of 
the health problem in both sexes and living in Northern 
Finland and comorbidity among women were also asso-
ciated with longer time until SRTW. When belonging 
to the category of the lowest probability of SRTW in 
respect to all baseline characteristics, median time until 
SRTW was 95 among men and 144 days among women 
(data not shown).
For anxiety disorders, median time until SRTW 
ranged from 22–27 days among men, depending on the 
age-group (appendix, table A, www.sjweh.fi/index.
php?page=data-repository). Among men, higher age 
and persistence of the health problem were associated 
with longer time until SRTW. Among women, the cor-
respondent factors were living in Northern Finland and 
persistence of the health problem. Office work in both 
sexes and service and care work among women tended 
to shorten the time until SRTW. When belonging to the 
category of the lowest probability of SRTW with respect 
to all baseline characteristics, median time until SRTW 
in anxiety disorders was 42 and 43 days among men and 
women, respectively (data not shown).
Median time until SRTW in men with intervertebral 
disc disorders was 30 days among the youngest partici-
pants and 38 days among those >56 years. Among men, 
none of the baseline characteristics were associated with 
the length of sickness absence until SRTW except for 
manual work (table 3). In men, there were too few cases 
and not enough statistical power in the case of two indi-
cators of the persistence of the health problem. Among 
women with intervertebral disc disorders, median time 
until SRTW was 35 days among the youngest participants 
and 43 days among those >56 years. In addition, manual 
work and the persistence of the health problem were 
associated with longer time until SRTW. Women living in 
Central Finland tended to return to work in a shorter time 
period than those living in the other parts of the country. 
When belonging to the category of the lowest probabil-
ity of SRTW with respect to all baseline characteristics, 
median time until SRTW was 90 and 102 days among 
men and women, respectively (data not shown).
Among men with back pain, median time until SRTW 
was 18 days among the youngest participants and 20 days 
among those >56 years. Among women, median time 
until SRTW was 20 days or 21 days depending on the 
age-group (Appendix, table B). For men, manual work 
and the persistence of the health problem and for women, 
also service and care work were associated with longer 
time until SRTW. The length of sickness absence until 
SRTW tended to be shorter among men with comorbid 
conditions and longer among women. When belonging 
to the category of the lowest probability of SRTW with 
respect to all baseline characteristics, median time until 
SRTW in back pain was 26 among men and 40 days 
among women (data not shown).
Discussion
This large cohort study showed that the unadjusted 
median time to SRTW was 21–46 days among men and 
22–41 days among women depending on the diagnosis. 
For back pain and anxiety disorders, employees suc-
ceeded in returning to work in a shorter time than in 
the case of depression and intervertebral disc disorders. 
There were no notable differences in time to SRTW 
between men and women except for depression. The 
length of sickness absence tended to be shorter for 
women than men with depression. It is possible that men 
and women are treated differently or they may differ in 
compliance as regards treatment of depression. It is also 
likely that men seek medical help for the symptoms of 
depression at a later stage than women. Older age was 
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Figure 1. Sustained return to work by diagnostic category and sex (unadjusted) (Kaplan-Meier analysis).
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Table 2. Hazard ratios (HR) for determinants and time to first sus-
tained return to work (SRTW) (Cox proportional hazards model with 
a cluster option). [95% CI=95% confidence interval; ATC=anatomical 
therapeutic chemical classification; SA=sickness absence]
Baseline characteristics Depression (ICD-10) F32, F33 and F34
Days until 
SRTW a 
(percentiles)
N HR 95% CI 25th 50th 75th
Men (N=2217)
Age
18–35 271 1.08 0.94–1.24 20 33 72
36–45 693 Ref 20 36 80
46–55 843 0.82 0.73–0.91 23 45 111
≥56 410 0.66 0.57– 0.76 27 57 168
Occupational group
Managers and professionals 653 Ref 20 36 80
Associate professionals and 
clerks
508 1.00 0.88–1.14 20 36 80
Service and care workers 344 1.06 0.91–1.24 20 34 73
Manual workers 710 0.91 0.81–1.03 21 40 91
Region
Southern Finland 1171 Ref 20 36 80
Central Finland 639 1.05 0.95–1.17 20 34 74
Northern Finland 407 0.94 0.82–1.08 20 39 88
Persistence of health problem
Sickness absence during  
previous year (ICD–10 F)
No 1619 Ref 20 36 80
Yes 598 0.93 0.84–1.03 21 39 89
Sickness absence during  
previous year (ICD–10 M)
No 2050 Ref 20 36 80
Yes 167 0.97 0.81–1.17 20 38 83
Sickness absence during  
previous year (other causes)
No 1905 Ref 20 36 80
Yes 312 0.98 0.87–1.11 20 37 82
Purchase of antidepressants b  
or hospitalization period for  
mental disorders c
No 1641 Ref 20 36 80
Yes 576 0.82 0.74–0.91 23 45 109
Reimbursed purchase of  
medication for musculoskeletal  
pain d or hospitalization period  
for musculoskeletal diseases c
No 2037 Ref 20 36 80
Yes 180 1.17 0.99–1.37 19 32 63
Comorbidity e
No 1997 Ref 20 36 80
Yes 220 0.93 0.77–1.11 21 39 89
continued
Table continued
Women (N=11 953)
Age
18–35 1658 1.02 0.96–1.09 18 31 61
36–45 3752 Ref 18 32 63
46–55 4340 0.91 0.87–0.96 19 34 73
≥56 2203 0.78 0.73–0.83 20 40 96
Occupational group
Managers and professionals 2637 Ref 18 32 63
Associate professionals and 
clerks
4084 1.00 0.96–1.06 18 31 62
Service and care workers 3421 1.04 0.98–1.10 18 31 61
Manual workers 1807 0.93 0.87–1.00 19 33 70
Region
Southern Finland 6707 Ref 18 32 63
Central Finland 3442 1.05 1.00–1.09 18 31 60
Northern Finland 1804 0.85 0.80–0.90 20 37 82
Persistence of health problem
Sickness absence during 
previous year (ICD–10 F)
No 8579 Ref 18 32 63
Yes 3374 0.89 0.85–0.92 20 35 76
Sickness absence during 
previous year (ICD–10 M)
No 10 647 Ref 18 32 63
Yes 1 306 0.89 0.84–0.95 20 35 76
Sickness absence during 
previous year (other causes)
No 10 138 Ref 18 32 63
Yes 1815 0.90 0.85–0.94 19 34 75
Purchase of antidepressants b  
or hospitalization period for  
mental disorders c
No 9113 Ref 18 32 63
Yes 2840 0.86 0.82–0.90 20 36 81
Reimbursed purchase of  
medication for musculoskeletal  
pain d or hospitalization period  
for musculoskeletal diseases c
No 10 541 Ref 18 32 63
Yes 1412 0.94 0.89–1.00 19 33 69
Comorbidity e
No 10 700 Ref 18 32 63
Yes 1253 0.90 0.84–0.96 19 34 74
a Estimated time to SRTW when in the reference category of other 
covariates.
b ATC: N06A, during: 30 days before – 7 days after the SA-period.
c during: 30 days before – 7 days after the sickness absence period.
d ATC: M01, M03, N02, during: 30 days before – 7 days after the 
SA-period.
e Entitlement to special reimbursements at the beginning of the sickness 
absence period (diabetes, rheumatoid arthritis, asthma/COPD, coronary 
heart disease).
rather consistently associated with longer time to SRTW 
throughout the diagnostic categories. Pregnancy-related 
back problems may explain the increased length of sick-
ness absence among younger women with back pain. As 
for occupational category, longer time to SRTW was 
required in physically demanding manual and service 
and care work in musculoskeletal diseases. Persistence 
of the health problem was rather consistently associated 
with longer time to SRTW, especially among women. 
Comorbid conditions predicted longer time to SRTW for 
depression and back pain among women. This finding is 
in accordance with earlier results from this same study 
cohort, which showed that RTW after depression-related 
work absence was delayed in the presence of other psy-
chiatric or somatic diseases (24).
National diagnosis specific guidelines on the length 
of sickness absence are currently under consideration 
in Finland following the example of several other coun-
tries. A recent survey among Finnish physicians (25) 
found, in accordance with corresponding earlier surveys 
carried out in Sweden and Norway, that some guidance 
on the length of sickness absence at least in the most 
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Table 3. Hazard ratios (HR) for determinants and time to first sus-
tained return to work (SRTW) (Cox proportional hazards model with 
a cluster option). [95% CI=95% confidence interval; ATC=anatomical 
therapeutic chemical classification; SA=sickness absence]
Baseline characteristics Intevertebral disc disorders (ICD-10 M51) 
Days until 
SRTW a 
(percentiles)
N HR 95% CI 25th 50th 75th
Men (N=825)
Age
18–35 130 1.11 0.91–1.35 17 30 58
36–45 237 Ref 18 32 61
46–55 268 0.88 0.72–1.06 19 35 70
≥56 190 0.81 0.65–1.02 20 38 76
Occupational group
Managers and professionals 165 Ref 18 32 61
Associate professionals and 
clerks
169 0.84 0.68–1.04 20 37 74
Service and care workers 146 0.86 0.68–1.09 19 36 70
Manual workers 344 0.67 0.54–0.83 23 48 104
Region
Southern Finland 336 Ref 18 32 61
Central Finland 211 1.12 0.93–1.34 17 30 58
Northern Finland 278 1.09 0.91–1.30 17 31 59
Persistence of health problem
Sickness absence during  
previous year (ICD–10 F)
No 802 Ref 18 32 61
Yes 23 1.00 0.59–1.71 18 32 61
Sickness absence during  
previous year (ICD–10 M)
No 501 Ref 18 32 61
Yes 324 0.98 0.84–1.14 18 32 63
Sickness absence during  
previous year (other causes)
No 721 Ref 18 32 61
Yes 104 1.12 0.92–1.36 17 30 58
Purchase of antidepressants b  
or hospitalization period for  
mental disorders c
No 807 Ref 18 32 61
Yes 18 0.68 0.40–1.14 23 47 101
Reimbursed purchase of  
medication for musculoskeletal  
pain d or hospitalization period  
for musculoskeletal diseases c
No 362 Ref 18 32 61
Yes 463 0.91 0.78–1.06 19 34 68
Comorbidity e
No 759 Ref 18 32 61
Yes 66 0.93 0.71–1.23 18 34 66
continued
Table continued
Women (N=2442)
Age
18–35 241 1.03 0.90–1.19 18 35 73
36–45 686 Ref 19 37 75
46–55 976 1.05 0.95–1.17 18 34 71
≥56 539 0.84 0.74–0.96 20 43 92
Occupational group
Managers and professionals 361 Ref 19 37 75
Associate professionals and 
clerks
846 1.01 0.89–1.14 19 37 75
Service and care workers 778 0.95 0.83–1.07 19 39 81
Manual workers 452 0.84 0.72–0.97 20 44 94
Region
Southern Finland 1 110 Ref 19 37 75
Central Finland 694 1.16 1.05–1.28 17 32 64
Northern Finland 638 1.00 0.89–1.12 19 37 75
Persistence of health problem
Sickness absence during 
previous year (ICD–10 F)
No 2 344 Ref 19 37 75
Yes 98 0.95 0.76 –1.18 19 39 81
Sickness absence during 
previous year (ICD–10 M)
No 1 349 Ref 19 37 75
Yes 1 093 0.89 0.82–0.97 20 41 87
Sickness absence during 
previous year (other causes)
No 2 115 Ref 19 37 75
Yes 327 0.90 0.80–1.02 19 41 84
Purchase of antidepressants b  
or hospitalization period for  
mental disorders c
No 2 335 Ref 19 37 75
Yes 107 0.73 0.60–0.88 22 51 113
Reimbursed purchase of  
medication for musculoskeletal  
pain d or hospitalization period  
for musculoskeletal diseases c
No 1 086 Ref 19 37 75
Yes 1 356 1.02 0.93–1.11 18 36 74
Comorbidity e
No 2 096 Ref 19 37 75
Yes 346 1.00 0.88–1.13 19 37 75
a Estimated time to SRTW when in the reference category of other 
covariates.
b ATC: N06A, during: 30 days before – 7 days after the SA-period.
c during: 30 days before – 7 days after the sickness absence period.
d ATC: M01, M03, N02, during: 30 days before – 7 days after the 
SA-period.
e Entitlement to special reimbursements at the beginning of the sickness 
absence period (diabetes, rheumatoid arthritis, asthma/COPD, coronary 
heart disease).
important diagnostic categories is needed. The existing 
guidelines mostly stem from expert opinion but it has 
been claimed that the evidence base of these recommen-
dations is unclear (15). This study sought to add scien-
tific evidence for the recommendations on the length of 
sickness absence in the Finnish context in order to pro-
mote SRTW. The analyses were restricted to four large 
diagnostic categories that are among the most prevalent 
causes of sickness benefit periods compensated by the 
Finnish national sickness insurance in Finland.
Direct comparisons of our study with previous studies 
on SRTW in mental disorders and musculoskeletal dis-
eases are problematic due to differences in study popula-
tions and study designs. Most of previous studies concern 
employees who have at baseline been absent from work 
for a longer period of time. SRTW is defined varyingly, 
however often as RTW for at least four or five weeks 
without recurrence of sickness absence (17, 20, 21, 
26–28). In only few of the previous studies findings were 
reported separately for men and women. To an extent, our 
findings can be contrasted to the Swedish national expert 
opinion-based guidelines on the length of work absence 
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in different diagnostic categories. In depression-related 
work absence, our findings are congruent with the Swed-
ish recommendations according to which there is large 
individual variation in the length of sickness absence 
needed. Our results indicated that especially among 
women in higher age-groups with a persistent health 
problem and comorbid conditions, a longer time was 
needed until SRTW when compared to younger employ-
ees with a more transient health condition and with no 
comorbidities. The Swedish guidelines propose that in 
mild depression, full time sickness absence is not always 
necessary, whereas partial sick leave can be considered. 
In moderate and severe depression, work ability can be 
reduced up till six months or longer. Because of the way 
we defined SRTW, we did not differentiate depression 
(F32) from recurrent depression (F33) or persistent mood 
disorders (F34) in our analyses.
In adjustment disorders (F43.2), the Swedish guide-
lines encourage to avoid sickness absence from work if 
possible. If sick leave is needed for other anxiety disor-
ders (F41), it should be restricted to 2–4 weeks. In our 
study, median time to SRTW in F40- F43 was roughly 
3 weeks, well in line with the Swedish guidelines. In 
intervertebral disc disorders (M51), we found that median 
time to SRTW was six weeks (41–42 days). And in back 
pain (M54) three weeks (21–22 days). Swedish guidelines 
state that in diagnostic categories of ICD-10 M51 and 
M54.4 (lumbago with sciatica) in physically light work, 
work ability can be reduced up till three weeks. In physi-
cally demanding work, it takes possibly up to six weeks 
until work ability is restored. Respectively, in M54.5 (low 
back pain) the guidelines instruct that work ability can 
be reduced up till 1 week and 2 weeks. Our results, even 
though not straight comparable, were in accordance with 
the Swedish guidelines indicating the importance of the 
nature of work in musculoskeletal diseases.
We utilized register data combining information 
from employers’ registers and several population regis-
ters. Although the study cohort represents a large scale 
of different occupations in the Finnish public sector, it 
might not be generalizable to other branches of indus-
try. A limitation is that short, uncompensated sickness 
absence periods (first ten weekdays of sickness absence) 
could not be included in the analyses. Thus our results 
may overestimate the length of sickness absence until 
SRTW. Another weakness is that we had no informa-
tion on medical treatment-, condition-, physician- or 
healthcare-system-related factors, which also have a 
role in SRTW. We assessed certain chronic diseases, 
namely, diabetes, rheumatoid arthritis, asthma/COPD or 
coronary heart disease, based on records of entitlement 
to special reimbursement for the medication purchases 
for these diseases. However, it is still possible that we 
missed some other comorbidities that could have influ-
enced the outcome. The present study provides evidence 
on how the length of sickness absence until SRTW is 
associated with the sociodemographic factors, including 
occupational group, persistence of the health problem 
and comorbid conditions. Information on these char-
acteristics is rather easily obtainable in an anamnestic 
interview carried out by the clinician in daily practice. 
However, it is important to note that RTW depends not 
only on the disease, individual or health-related factors 
but also on the private and living conditions, features of 
the work environment as well as cultural and organiza-
tional factors. We were not able to take all these factors 
into account and more research is needed on this matter. 
The use of partial sick leave and work modifications in 
returning to work could not be examined in this study.
In conclusion, this large cohort study adds scientific 
evidence on the association between the length of sick-
ness absence and SRTW in four important diagnostic 
categories among public sector employees in Finland. 
Half of the sickness absence periods resulted in SRTW in 
21–46 days depending on the diagnosis behind the work 
disability in question. In particular, sociodemographic and 
health-related factors were associated with the length of 
sickness absence. It is important to interpret these results 
cautiously because the length of sickness absence is also 
related to a set of uninvestigated factors, such as the work 
environment, the nature of the job, and the extent to which 
the workplace is prepared to accommodate the disability. 
Certifying physicians in Finland have expressed a need 
for guidelines concerning the need and length of sick-
ness absence (25). At this point, such guidelines could 
be based on expert opinion supplemented with research 
findings, such as the results of this study.
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